E 13 Pill - white oval, 22mm
Pill with imprint E 13 is White, Oval and has been identified as Levetiracetam 1000 mg. It is supplied by Aurobindo Pharma.
Levetiracetam is used in the treatment of Seizures; Epilepsy and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy. Levetiracetam 1000 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for E 13
Levetiracetam
- Imprint
- E 13
- Strength
- 1000 mg
- Color
- White
- Size
- 22.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Pyrrolidine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma
- Inactive Ingredients
-
corn starch,
silicon dioxide,
povidone k30,
magnesium silicate,
magnesium stearate,
hypromellose 2910 (5 mPa.s),
titanium dioxide,
polyethylene glycol 400,
water
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 16714-0357 | NorthStar Rx LLC |
| 65862-0315 | Aurobindo Pharma Limited |
| 68084-0893 (Discontinued) | Amerisource Health Services |
Related images for "E 13"
More about levetiracetam
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (433)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: pyrrolidine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Levetiracetam oral/injection drug information
- Levetiracetam Extended-Release Tablets
- Levetiracetam Injection
- Levetiracetam Tablets
- Levetiracetam Oral Solution
Other brands
Keppra, Keppra XR, Spritam, Elepsia XR, ... +2 more
Professional resources
- Levetiracetam monograph
- Levetiracetam (FDA)
- Levetiracetam Extended Release Tablets (FDA)
- Levetiracetam Injection (FDA)
- Levetiracetam Solution (FDA)
Other brands
Keppra, Keppra XR, Spritam, Elepsia XR, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.